GILD Investors Have Opportunity to Join Gilead Sciences, Inc. Fraud Investigation with the Schall Law Firm

Summary
LOS ANGELES , July 16, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announce...
LOS ANGELES , July 16, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Gilead Sciences, Inc. ("Gilead" or "the Company") (NASDAQ: GILD) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Tags
GILD
Related Articles
Gilead (GILD) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
GILD
PositiveEU regulator backs Gilead's twice-yearly injection for HIV prevention
GILD
NeutralGilead Receives Positive CHMP Opinions Under Accelerated Review From European Medicines Agency for Twice-Yearly Lenacapavir for HIV Prevention
GILD
Neutral